Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
about
EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's diseaseA note from history: Landmarks in history of cancer, part 7.Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis.ABVE-PC and modified BEACOPP regimen in Indian children with Hodgkin lymphoma: Feasibility and efficacyRole of chemotherapy in Hodgkin's lymphoma.A method for detection of doxorubicin-induced cardiotoxicity: Flow-mediated vasodilation of the brachial artery.Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.Historical review of lymphomas.Historical review of Hodgkin's disease.An A,B,C,D of cancer chemotherapy.Hodgkin's disease in a community oncology center: ten years' experienceRole of Radiotherapy in Modern Treatment of Hodgkin's LymphomaHodgkin's lymphoma therapy: past, present, and future.Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infectionA Historical Tale of Two Lymphomas: Part I: Hodgkin lymphomaPrognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.Approach to Hodgkin's lymphoma in the new millennium.Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancerThe Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of RadiotherapyRandomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study.Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapyA case of Hodgkin's lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVDIntensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphomaEmerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab VedotinLate relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraFetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report und Review of the Current Literature.Late cardiopulmonary toxicity after treatment for Hodgkin's diseaseThe case for chemotherapy alone for limited-stage Hodgkin's lymphoma.Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.[The role of radiotherapy and chemotherapy in the treatment of lymphomas]Gingival enlargement as an early diagnostic indicator in therapy-related acute myeloid leukemia: A rare case report and review of literatureAdapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literatureManagement of lymphoma in pregnancy.Treatment of Hodgkin's disease: a twenty-year follow-up of patients at a center in Korea.Treatment outcome of limited stage Hodgkin's disease.Hodgkin's lymphoma: current treatment strategies and novel approaches.The impact of lymphoma and treatment on male fertility.Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances
P2860
Q28373416-70D05788-7EAC-4DDC-9EAE-0C7D7D7E4A45Q30931923-BCD786B3-7CAC-4940-A28C-0ACE702E2CECQ33208378-C9F183EA-B5A4-42FE-B848-56EE059295DBQ33432165-A162E425-9BC2-4873-ADDC-BCB7045C6943Q33761103-CE51BAD4-CDA9-45F0-9F52-69CCD9D34EFCQ33807892-A3ABE1FF-B5F4-4C71-BFFD-F66CC1BCB718Q33935351-E9AA3B88-AB73-496A-AB4F-43068B637747Q33962044-CFEE0BBC-D142-4C43-ABAD-401A77388168Q34039931-84DBFF83-9DC8-4067-8D03-468C87399BE2Q34052652-338CEA48-1C67-4C32-AB4E-3224983B1891Q34111470-549A323B-5304-473B-9F5A-EEF645F82640Q34235785-B0E75CDF-10B1-4E13-85FB-C3A4D4F296E0Q34296914-3CC6E85D-8509-4AB7-9CF0-C92907642F5FQ34335424-2E710C3F-43E7-43BF-B635-32241314DF86Q34479660-1D571645-3DBE-4D87-845C-CB167F7777F2Q34548300-B777FC79-F45D-4348-8CFF-4D8F19C36490Q34580600-3F89907E-2B25-46B3-8FB3-CBBF152BD175Q34618624-39761253-84CB-4B78-B756-2DB30B726555Q34639390-0203A842-E195-43C9-87C1-9AB0C6452891Q34645722-BBA88784-43A3-4B73-B1CC-59F2C174E4C2Q34993792-18DEF601-5F29-49F4-BDBE-9E547B31FDACQ35141276-1FEA87C8-546F-4B3C-9ACB-015AA99971DEQ35223515-0FB559BE-C0B0-4BB8-AE80-EE5287B50C0CQ35602142-B8ABC0C2-025A-47AA-B3D8-53DB0D9D1B63Q35669134-D4A2E04C-3ED3-4808-8347-9F71B905F66EQ35717972-3A9CAEDC-F91A-4F68-8D82-80E3E5E0D7F6Q35789387-3A5B347B-A62A-4978-9282-069280A5E445Q35994040-1B0DF17C-F053-4E90-8435-7DC0E406F958Q36182790-A1F9476E-1B94-462A-84F8-E461FF7F50DFQ36440046-974EF527-512C-47FD-9BAF-FCD1D0A224D2Q36674900-7D9A3759-E9CB-4783-B402-9D6441314E65Q37020294-E6FC58E3-78AF-4BDC-9AFA-C91DDBD73349Q37126978-09E7BE67-2A94-4B05-A70B-B749267CACB4Q37178817-3B342B39-647E-4CA0-967F-89E1BD7CC03BQ37186296-471CB07A-6D29-49A3-92D1-1F34452764ABQ37205598-5DD43476-00F4-43D4-ABA1-893DF1F5232DQ37447063-3134B50F-6939-4759-A1D6-A40FA89388E8Q37810114-8DCD8656-2464-4BD1-B94E-19C4D4BA62C1Q37810970-55C11CE6-C4C0-4327-BD27-19C540DD2F8FQ37872044-593C01AC-430B-4DD8-B029-DB87FED8A97C
P2860
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
description
1975 nî lūn-bûn
@nan
1975 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@ast
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@en
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@nl
type
label
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@ast
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@en
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@nl
prefLabel
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@ast
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@en
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@nl
P2093
P3181
P1433
P1476
Combination chemotherapy of Ho ...... dazole carboxamide versus MOPP
@en
P2093
P3181
P356
10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7
P407
P577
1975-07-01T00:00:00Z